Bristol Myers Squibb (BMY) Asset Utilization Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Asset Utilization Ratio for 17 consecutive years, with 0.56 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 10.8% year-over-year to 0.56 in Q2 2026; TTM through Jun 2026 was 0.56, a 10.8% increase from a year earlier, with the FY2025 full-year figure at 0.53, up 2.58% from the prior year.
• Asset Utilization Ratio was 0.56 for Q2 2026 at Bristol Myers Squibb, up from 0.55 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.56 in Q2 2026 and troughed at 0.44 in Q1 2022.
• A 5-year average of 0.49 and a median of 0.48 in 2023 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio grew 19.29% in 2022 and fell 2.26% in 2024, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.47 in 2022, then gained by 2.0% to 0.48 in 2023, then gained by 7.4% to 0.52 in 2024, then retreated by 0.57% to 0.52 in 2025, then grew by 9.57% to 0.56 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.56 (Q2 2026), 0.55 (Q1 2026), and 0.52 (Q4 2025), per Business Quant data.